Cargando…

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas

PURPOSE: Glioblastoma multiforme (GBM) is the most common of the malignant and invasive gliomas. High grade glioma is prone to relapse and has a poor prognosis. However, there is a big difference in terms of survival time with the same grade glioma. Cluster of differentiation 44 (CD44) is an indicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Si, Daolin, Yin, Fei, Peng, Jing, Zhang, Guangying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006859/ https://www.ncbi.nlm.nih.gov/pubmed/32099472 http://dx.doi.org/10.2147/CMAR.S233423

Ejemplares similares

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

High expression of Dll4 and CD44V6 is associated with clinicopathological characteristics and poor prognosis in osteosarcoma patients
por: Xie, Haiyang, et al.
Publicado: (2021)

Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2018)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.
por: Joensuu, H., et al.
Publicado: (1993)

High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
por: Ma, Ke, et al.
Publicado: (2023)

Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
por: Chen, Qi, et al.
Publicado: (2019)

Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
por: Phan, Thi Le, et al.
Publicado: (2021)

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Predictive Value of CD44 for Prognosis in Patients with Breast Cancer
por: Roosta, Yousef, et al.
Publicado: (2020)

High expression of CHML predicts poor prognosis of multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

BNIPL-2 expression is correlated with the prognosis and regulates the proliferation of colorectal cancer through CD44
por: Gao, Lei, et al.
Publicado: (2019)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
por: Vega, Francisco M., et al.
Publicado: (2020)

Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
por: Lee, Hye-Jin, et al.
Publicado: (2015)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma
por: Meng, Delong, et al.
Publicado: (2014)

SWAP-70 promotes glioblastoma cellular migration and invasion by regulating the expression of CD44s
por: Shi, Lin, et al.
Publicado: (2019)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
por: Tempfer, C., et al.
Publicado: (1998)

High level of CD73 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Xu, Ya-ping, et al.
Publicado: (2021)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

High expression of GMNN predicts malignant progression and poor prognosis in ACC
por: Zhao, Xinzhao, et al.
Publicado: (2022)

High expression of UBE2T predicts poor prognosis and survival in multiple myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Xu, Wenxiong, et al.
Publicado: (2022)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

Association between glioblastoma cell‐derived vessels and poor prognosis of the patients
por: Mei, Xin, et al.
Publicado: (2020)

High DHCR7 Expression Predicts Poor Prognosis for Cervical Cancer
por: Zou, Jing, et al.
Publicado: (2022)

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
por: Papadaki, Chara, et al.
Publicado: (2020)

MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44
por: Yeh, Margaret, et al.
Publicado: (2021)

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_51jpqnc8lq4j3q0v625tidkcbf